在智利公共卫生系统明确的健康保障下,肿瘤服务的表达和有效需求的特征。

IF 0.8 Q2 MEDICINE, GENERAL & INTERNAL
Carolina De la Fuente, Paula Bedregal, Paula Zamorano, Oscar Arteaga, Cristian Rebolledo, Camilo Oñate, Pedro Zitko
{"title":"在智利公共卫生系统明确的健康保障下,肿瘤服务的表达和有效需求的特征。","authors":"Carolina De la Fuente, Paula Bedregal, Paula Zamorano, Oscar Arteaga, Cristian Rebolledo, Camilo Oñate, Pedro Zitko","doi":"10.5867/medwave.2025.07.3070","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Efficient and effective cancer management is a priority for the Chilean healthcare system. In recent years, significant progress has been made through public policies integrating management at different levels (micro, meso, and macro). However, gaps between the population's needs, service availability, and effective demand may impact health outcomes.</p><p><strong>Objective: </strong>To describe the national effective demand for prioritized cancer services within the Chilean public healthcare system.</p><p><strong>Methods: </strong>A descriptive comparative analysis was conducted using data from the public sector Health Guarantees Management Information System between 2018 and 2022. The rates of new cases granted health guarantees by intervention type and the analysis of delayed guarantees were performed.</p><p><strong>Results: </strong>A total of 3.8 million new cases of explicit health guarantees and 3.9 million fulfilled opportunity guarantees were included. The rates of primary treatment opportunity guarantee by tracer intervention declined in 2020 and 2021, while delayed guarantees showed an increasing trend throughout the entire period. Effective demand varied across cancer types. Breast cancer, preventive cholecystectomy, and gastric cancer exhibited the largest sex-based differences in new cases and primary treatment. Delayed guarantees were similar between sexes, except for breast cancer.</p><p><strong>Conclusions: </strong>This study provides valuable insights into the demand for cancer services in Chile and the performance of the public healthcare system concerning sex and cancer type, highlighting the impact of the COVID-19 pandemic. The findings emphasize the need to strengthen the public system's response capacity to reduce gaps and improve equity in oncological care.</p>","PeriodicalId":18597,"journal":{"name":"Medwave","volume":"25 7","pages":"e3070"},"PeriodicalIF":0.8000,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Characterization of the expressed and effective demand for oncology services under the explicit health guarantees of the Chilean public health system.\",\"authors\":\"Carolina De la Fuente, Paula Bedregal, Paula Zamorano, Oscar Arteaga, Cristian Rebolledo, Camilo Oñate, Pedro Zitko\",\"doi\":\"10.5867/medwave.2025.07.3070\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Efficient and effective cancer management is a priority for the Chilean healthcare system. In recent years, significant progress has been made through public policies integrating management at different levels (micro, meso, and macro). However, gaps between the population's needs, service availability, and effective demand may impact health outcomes.</p><p><strong>Objective: </strong>To describe the national effective demand for prioritized cancer services within the Chilean public healthcare system.</p><p><strong>Methods: </strong>A descriptive comparative analysis was conducted using data from the public sector Health Guarantees Management Information System between 2018 and 2022. The rates of new cases granted health guarantees by intervention type and the analysis of delayed guarantees were performed.</p><p><strong>Results: </strong>A total of 3.8 million new cases of explicit health guarantees and 3.9 million fulfilled opportunity guarantees were included. The rates of primary treatment opportunity guarantee by tracer intervention declined in 2020 and 2021, while delayed guarantees showed an increasing trend throughout the entire period. Effective demand varied across cancer types. Breast cancer, preventive cholecystectomy, and gastric cancer exhibited the largest sex-based differences in new cases and primary treatment. Delayed guarantees were similar between sexes, except for breast cancer.</p><p><strong>Conclusions: </strong>This study provides valuable insights into the demand for cancer services in Chile and the performance of the public healthcare system concerning sex and cancer type, highlighting the impact of the COVID-19 pandemic. The findings emphasize the need to strengthen the public system's response capacity to reduce gaps and improve equity in oncological care.</p>\",\"PeriodicalId\":18597,\"journal\":{\"name\":\"Medwave\",\"volume\":\"25 7\",\"pages\":\"e3070\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-08-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medwave\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5867/medwave.2025.07.3070\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medwave","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5867/medwave.2025.07.3070","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

简介:高效和有效的癌症管理是智利医疗保健系统的优先事项。近年来,通过公共政策整合微观、中观和宏观等不同层面的管理,取得了显著进展。然而,人口需求、服务可得性和有效需求之间的差距可能会影响健康结果。目的:描述智利公共卫生系统对优先癌症服务的国家有效需求。方法:采用2018 - 2022年公共部门卫生保障管理信息系统数据进行描述性比较分析。按干预类型对新病例给予健康保障的比率进行了统计,并对延迟保障进行了分析。结果:共纳入新增显性健康保障380万例,实现机会保障390万例。示踪剂干预初级治疗机会保障率在2020年和2021年下降,而延迟保障率在整个时期呈上升趋势。不同癌症类型的有效需求不同。乳腺癌、预防性胆囊切除术和胃癌在新发病例和初次治疗方面表现出最大的性别差异。除了乳腺癌之外,性别之间的延迟担保是相似的。结论:本研究为智利对癌症服务的需求以及公共医疗系统在性别和癌症类型方面的表现提供了有价值的见解,突出了COVID-19大流行的影响。研究结果强调需要加强公共系统的反应能力,以缩小差距,提高肿瘤护理的公平性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Characterization of the expressed and effective demand for oncology services under the explicit health guarantees of the Chilean public health system.

Introduction: Efficient and effective cancer management is a priority for the Chilean healthcare system. In recent years, significant progress has been made through public policies integrating management at different levels (micro, meso, and macro). However, gaps between the population's needs, service availability, and effective demand may impact health outcomes.

Objective: To describe the national effective demand for prioritized cancer services within the Chilean public healthcare system.

Methods: A descriptive comparative analysis was conducted using data from the public sector Health Guarantees Management Information System between 2018 and 2022. The rates of new cases granted health guarantees by intervention type and the analysis of delayed guarantees were performed.

Results: A total of 3.8 million new cases of explicit health guarantees and 3.9 million fulfilled opportunity guarantees were included. The rates of primary treatment opportunity guarantee by tracer intervention declined in 2020 and 2021, while delayed guarantees showed an increasing trend throughout the entire period. Effective demand varied across cancer types. Breast cancer, preventive cholecystectomy, and gastric cancer exhibited the largest sex-based differences in new cases and primary treatment. Delayed guarantees were similar between sexes, except for breast cancer.

Conclusions: This study provides valuable insights into the demand for cancer services in Chile and the performance of the public healthcare system concerning sex and cancer type, highlighting the impact of the COVID-19 pandemic. The findings emphasize the need to strengthen the public system's response capacity to reduce gaps and improve equity in oncological care.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medwave
Medwave MEDICINE, GENERAL & INTERNAL-
CiteScore
2.60
自引率
8.30%
发文量
50
审稿时长
12 weeks
期刊介绍: Medwave is a peer-reviewed, biomedical and public health journal. Since its foundation in 2001 (Volume 1) it has always been an online only, open access publication that does not charge subscription or reader fees. Since January 2011 (Volume 11, Number 1), all articles are peer-reviewed. Without losing sight of the importance of evidence-based approach and methodological soundness, the journal accepts for publication articles that focus on providing updates for clinical practice, review and analysis articles on topics such as ethics, public health and health policy; clinical, social and economic health determinants; clinical and health research findings from all of the major disciplines of medicine, medical science and public health. The journal does not publish basic science manuscripts or experiments conducted on animals. Until March 2013, Medwave was publishing 11-12 numbers a year. Each issue would be posted on the homepage on day 1 of each month, except for Chile’s summer holiday when the issue would cover two months. Starting from April 2013, Medwave adopted the continuous mode of publication, which means that the copyedited accepted articles are posted on the journal’s homepage as they are ready. They are then collated in the respective issue and included in the Past Issues section.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信